Westfield Capital Management’s 89bio ETNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,291,369
Closed -$48.4M 248
2025
Q3
$48.4M Sell
3,291,369
-79,448
-2% -$810K 0.2% 152
2025
Q2
$33.1M Sell
3,370,817
-523,924
-13% -$4.34M 0.14% 176
2025
Q1
$28.3M Buy
3,894,741
+7,947
+0.2% +$69.5K 0.14% 162
2024
Q4
$30.4M Buy
3,886,794
+880,756
+29% +$7.25M 0.13% 167
2024
Q3
$22.2M Buy
3,006,038
+686,673
+30% +$5.77M 0.1% 179
2024
Q2
$18.6M Buy
2,319,365
+155,218
+7% +$1.39M 0.09% 187
2024
Q1
$25.2M Buy
2,164,147
+402,999
+23% +$4.46M 0.13% 180
2023
Q4
$19.7M Buy
1,761,148
+449,262
+34% +$4.13M 0.11% 180
2023
Q3
$20.3M Buy
1,311,886
+476,655
+57% +$8M 0.14% 170
2023
Q2
$15.8M Buy
835,231
+80,021
+11% +$1.41M 0.1% 176
2023
Q1
$11.5M Buy
+755,210
New +$9.85M 0.08% 177

Other funds holding ETNB

Westfield Capital Management's ETNB Position: Q4 2025 in Review

Westfield Capital Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 3,291,369 shares — an estimated $48.4M sold.

Westfield Capital Management first reported a position in ETNB in Q1 2023 and held it in 11 quarters. The position peaked at $48.4M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Westfield Capital Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Westfield Capital Management sold 3,291,369 89bio shares in Q4 2025, an estimated $48.4M.
  • Westfield Capital Management first reported a position in 89bio in Q1 2023 and held it in 11 quarters.
  • Westfield Capital Management's 89bio position peaked at $48.4M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Westfield Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.